JP2008509222A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509222A5
JP2008509222A5 JP2007525700A JP2007525700A JP2008509222A5 JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5 JP 2007525700 A JP2007525700 A JP 2007525700A JP 2007525700 A JP2007525700 A JP 2007525700A JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5
Authority
JP
Japan
Prior art keywords
methyloxy
naphthyridin
dihydro
oxo
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509222A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028107 external-priority patent/WO2006020561A2/en
Publication of JP2008509222A publication Critical patent/JP2008509222A/ja
Publication of JP2008509222A5 publication Critical patent/JP2008509222A5/ja
Pending legal-status Critical Current

Links

JP2007525700A 2004-08-09 2005-08-09 抗菌剤 Pending JP2008509222A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59993104P 2004-08-09 2004-08-09
PCT/US2005/028107 WO2006020561A2 (en) 2004-08-09 2005-08-09 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008509222A JP2008509222A (ja) 2008-03-27
JP2008509222A5 true JP2008509222A5 (enExample) 2008-09-25

Family

ID=35908073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525700A Pending JP2008509222A (ja) 2004-08-09 2005-08-09 抗菌剤

Country Status (4)

Country Link
US (1) US20070161627A1 (enExample)
EP (1) EP1784410A4 (enExample)
JP (1) JP2008509222A (enExample)
WO (1) WO2006020561A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE484509T1 (de) * 2004-08-02 2010-10-15 Glaxo Group Ltd Antibakterielle mittel
JP2008528586A (ja) * 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1845995A4 (en) * 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
US7709496B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Antibacterial agents
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
PT2137196E (pt) * 2007-04-20 2010-12-16 Glaxo Group Ltd Compostos tricíclicos contendo azoto como agentes antibacterianos
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
AR090844A1 (es) * 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
AR101674A1 (es) 2014-08-22 2017-01-04 Glaxosmithkline Ip Dev Ltd Uso de un compuesto tricíclico que contiene nitrógeno
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2020169593A1 (en) 2019-02-19 2020-08-27 Univerza V Ljubljani Antibacterials based on monocyclic fragments coupled to aminopiperidine naphthyridine scaffold

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69715658T2 (de) * 1996-12-13 2003-05-22 Aventis Pharmaceuticals Inc., Collegeville Sulfonsäure oder sulfonylamino n-(heteroaralkyl)-azaheterocyclylamid verbindungen
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
US6602864B1 (en) * 1996-12-13 2003-08-05 Aventis Pharma Deutschland Gmbh Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
GB9824612D0 (en) * 1998-11-10 1999-01-06 Glynwed Metal Processing Limit A blind fastening device
CN1452619A (zh) * 2000-07-26 2003-10-29 史密斯克莱·比奇曼公司 具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
JP4602903B2 (ja) * 2002-10-10 2010-12-22 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー 抗菌活性を有する新規化合物
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
GB0412467D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
JP2008506695A5 (enExample)
JP2008507543A5 (enExample)
JP2009532504A5 (enExample)
JP2008505920A5 (enExample)
JP4654035B2 (ja) 抗菌剤
JP2008502689A5 (enExample)
EP3841100A1 (en) Proteolysis targeting chimeric (protac) compound with e3 ubiquitin ligase binding activity and targeting alpha-synuclein protein for treating neurodegenerative diseases
JP2005525324A5 (enExample)
JP2013525438A5 (enExample)
WO2016197114A1 (en) Tank-binding kinase-1 protacs and associated methods of use
JP2008505926A5 (enExample)
JP4704755B2 (ja) 抗菌剤
JP2005504080A5 (enExample)
ES2190570T3 (es) Compuestos heterociclicos de piperazinilo para el tratamiento de la demencia.
SE0402735D0 (sv) Novel compounds
TW200643015A (en) 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
JP2007516194A5 (enExample)
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
AU2850101A (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
RU2000105266A (ru) Производные 1-(n-фениламиноалкил)-пиперазина, замещенные в положении 2 фенильного кольца
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
AR060287A1 (es) Compuesto de 5,6 dihidro-3h-pirrolo[1,2,3-de]quinoxalini-3-ona, su uso para preparar un medicamento, composicion farmaceutica que lo comprende y compuesto intermediario util para su preparacion
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
JP2008508359A5 (enExample)